Difei Yang

Why This Bluebird Bio Analyst Sees Over 125% Upside Ahead

Mizuho Upgrades Audentes On Promising Gene Therapy Candidate

FibroGen Upgraded By Mizuho On Continued R&D Progress

Mizuho Upgrades Audentes On Promising Gene Therapy Candidate

FibroGen Upgraded By Mizuho On Continued R&D Progress

Concert Pharma Drops On Patent Litigation Setback; Mizuho Downgrades

ZELTIQ Is The Leader In Non-Invasive Fat Reduction, Says Aegis

Concert Pharma Drops On Patent Litigation Setback; Mizuho Downgrades

ZELTIQ Is The Leader In Non-Invasive Fat Reduction, Says Aegis

Axsome Therapeutics: Teaching Old Drugs New Tricks

Recro Pharma Offers A Non-Opioid Alternative For Pain Management; Brean Assumes With Buy Rating

Difei Yang Recent News

Brean Assumes SCYNEXIS Shares At Buy, Sees 300% Upside

Alder BioPharma Could Lead The Migraine Market; Brean Assumes With Buy Rating

Brean Likes Nektar Therapeutics' Upcoming Launches; Assumes Coverage At Buy

Akebia Price Target Lowered, Still A Buy At Brean

Brean Downgrades Pernix Therapeutics, Warns Of Unclear Path To Profitability

Galencia's Bid For Relypsa Is 'Reasonable,' Another Bidder 'Unlikely'

Evoke Pharma Plunges 70%, Prompting Brean To Downgrade The Stock From Buy

June Data On Relypsa's Veltassa 'Very Encouraging'

Brean Downgrades Revance Therapeutics Following RT-001 Fail

Brean Reiterates Buy Rating On Revance Ahead Of Upcoming Phase 3 Read-Out

Brean Thinks Relypsa's Veltassa Sales Were 'Solid, But Not Impressive'

Brean's Yang: Relypsa Monthly Prescription Data Met Expectations, A Takeout Still 'Probable'

Brean Initiates Relypsa With Buy Rating, $26 Target

Brean: Pernix Deal Could Occur Soon, Stock Worth $8

Brean Reiterates Buy On Horizon Pharma, Likes Crealta Deal

Premium No Longer Deserved? Why Brean's Difei Yang Is Downgrading Horizon Pharma

Brean Capital Initiates Coverage On Osiris Therapeutics

Brean Capital Initiates Coverage On Zogenix

Zohydro Gains Massachusetts Approval, Acts As Minor Catalyst For Zogenix

Could ViroPharma Benefit from Multiple Generic Versions of VANCOCIN?